Cleo Diagnostics soars after approval of its cancer screening test

Cleo Diagnostics' stock surged following the approval of its ovarian cancer screening test.

Published 3h1 sourceNotableupdated 2h

≈ 16sSpeed

The fact

This innovative test could revolutionize early diagnosis of the disease.

The Australian company's growth prospects have strengthened.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on September 3, 2026